The UNITY Vitreoretinal Cataract System (VCS) and UNITY Cataract System (CS) have been introduced in India, according to a recent announcement from Alcon, a leader in eye care committed to helping people see brilliantly.

A standalone cataract system (CS), which will be commercially available in the upcoming months, and a combination console (VCS), which is now available, are the two versions of the new, adaptable platform.

This platform is intended to provide outstanding results for patients while delivering greater efficiency for cataract and vitreoretinal surgery. The systems include a number of first-to-market innovations, such as the cutting-edge UNITY Intelligent Fluidics system, HYPERVIT 30K, and UNITY 4D Phaco, that are intended to provide revolutionary surgical innovation for cataract and vitreoretinal surgery.

Surgeons can perform more physiologic procedures with UNITY VCS/CS without sacrificing effectiveness. “Alcon has a long history of developing vitreoretinal and phaco technologies for surgical ophthalmology.” Amar Vyas, Country Head of Alcon India, stated, “With UNITY VCS/CS, we are introducing over a dozen innovations designed to deliver significant efficiencies for surgery centers across the globe.”

We are particularly pleased to introduce these cutting-edge equipment options to India, a nation where the need for sophisticated eye care is expanding quickly. We hope to improve the stability and efficiency of healthcare practitioners and raise the bar for patient care throughout India by providing ophthalmic surgeons with state-of-the-art equipment.

With first-to-market improvements, the combination vitreoretinal and cataract system cleverly alters both cataract and vitreoretinal surgery.

Alcon’s UNITY portfolio of next-generation surgical equipment solutions includes UNITY VCS/CS, which is the first device to be made available. Intelligent Services Solutions, such as specific remote service options and predictive service capabilities to reduce downtime, are advantageous to UNITY VCS/CS users. In India, UNITY VCS/CS has been approved by the Central Drugs Standard Control Organization (CDSCO).